Spok Holdings, Inc.
SPOK Healthcare Health Information Services
Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024. In the quarter to June 2026, revenue fell 1.89%, EPS fell 9.09% and free cash flow fell 2.00%, each against the same quarter a year earlier. Dividend growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow SPOK
Spok Holdings, Inc. (SPOK) EV/Sales
As of 16 October 2026, Spok Holdings, Inc. (SPOK) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.5× (August 2021) to 2.6× (August 2025); the current reading is higher than 69% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.8× | (18.09%) |
| FY2024 | 2.1× | 8.33% |
| FY2023 | 2.0× | 103.25% |
| FY2022 | 1.0× | 14.20% |
| FY2021 | 0.9× | (4.86%) |
| FY2020 | 0.9× | (7.85%) |
| FY2019 | 1.0× | (4.81%) |
| FY2018 | 1.0× | (13.71%) |
| FY2017 | 1.2× | (33.19%) |
| FY2016 | 1.8× | 19.40% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | (5.22%) |
| Mar 2026 | 1.5× | (12.95%) |
| Dec 2025 | 1.8× | (26.34%) |
| Sep 2025 | 2.4× | (2.15%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AMWL American Well Corporation compare | 0.0× |
| DH Definitive Healthcare Corp. compare | 0.4× |
| SY So-Young International Inc. Sponsored ADR compare | 0.5× |
| HCAT Health Catalyst, Inc. compare | 0.6× |
| SPOK Spok Holdings, Inc. | 1.5× |
| OPRX OptimizeRx Corp. compare | 1.6× |
| CSLT Castlight Health, inc. compare | 1.9× |
| CARL Carlsmed, Inc. compare | 4.6× |
| CTEV Claritev Corporation compare | 5.0× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)